| Date Filed | Type | Description |
| 06/08/2023 |
4
| MEISTER PAUL M (10% Owner) has filed a Form 4 on Telesis Bio Inc.|
Txns:
| Granted 108,270 shares
@ $0
Granted 162,406 options to buy
@ $1.33, valued at
$216k
|
|
| 06/08/2023 |
3
| Novalis LifeSciences Investments II GP, LLC (10% Owner) has filed a Form 3 on Telesis Bio Inc. |
| 06/07/2023 |
4
| Northpond Ventures GP, LLC (10% Owner) has filed a Form 4 on Telesis Bio Inc.|
Txns:
| Granted 80,000 options to buy
@ $100, valued at
$8M
Granted 3,385,097 options to buy
@ $0
Granted 1,692,549 options to buy
@ $0 |
|
| 06/07/2023 |
4
| BroadOak Fund IV, LLC (10% Owner) has filed a Form 4 on Telesis Bio Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.3633, valued at
$47.3k
Granted 423,137 options to buy
@ $2.5996, valued at
$1.1M
Granted 846,274 options to buy
@ $2.5996, valued at
$2.2M
|
|
| 06/07/2023 |
4
| Snider William (10% Owner) has filed a Form 4 on Telesis Bio Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.3633, valued at
$47.3k
Granted 423,137 options to buy
@ $2.5996, valued at
$1.1M
Granted 846,274 options to buy
@ $2.5996, valued at
$2.2M
|
|
| 06/07/2023 |
4
| Nelson Todd Robert (President & CEO) has filed a Form 4 on Telesis Bio Inc.|
Txns:
| Granted 25,000 options to buy
@ $2.3633, valued at
$59.1k
Granted 528,922 options to buy
@ $2.5996, valued at
$1.4M
Granted 1,057,843 options to buy
@ $2.5996, valued at
$2.7M
|
|
| 05/08/2023 |
4
| Nelson Todd Robert (President & CEO) has filed a Form 4 on Telesis Bio Inc.|
Txns:
| Sold 2,575 shares
@ $2.8261, valued at
$7.3k
|
|
| 05/08/2023 |
4
| Gibson Daniel Glenn (Chief Technology Officer) has filed a Form 4 on Telesis Bio Inc.|
Txns:
| Sold 1,190 shares
@ $2.8261, valued at
$3.4k
|
|
| 05/08/2023 |
4
| Cutler Rob (Chief Legal Officer) has filed a Form 4 on Telesis Bio Inc.|
Txns:
| Sold 1,174 shares
@ $2.8261, valued at
$3.3k
|
|
| 05/05/2023 |
3
| Cutler Rob (Chief Legal Officer) has filed a Form 3 on Telesis Bio Inc. |
| 11/14/2022 |
4
| Nelson Todd Robert (President & CEO) has filed a Form 4 on Telesis Bio Inc.|
Txns:
| Bought 122,516 shares
@ $1.5634, valued at
$191.5k
|
|
| 08/08/2022 |
4
| Hunter Brent M. (Vice President, Finance & PFO) has filed a Form 4 on Codex DNA, Inc.|
Txns:
| Granted 125,000 options to buy
@ $2.08, valued at
$260k
|
|
| 08/08/2022 |
4
| Gibson Daniel Glenn (Chief Technology Officer) has filed a Form 4 on Codex DNA, Inc.|
Txns:
| Granted 100,000 options to buy
@ $2.08, valued at
$208k
|
|
| 08/08/2022 |
4
| Esser Eric Eugene (COO) has filed a Form 4 on Codex DNA, Inc.|
Txns:
| Granted 50,000 options to buy
@ $2.08, valued at
$104k
|
|
| 07/22/2022 |
4
| TUMOLO ANNETTE (Director) has filed a Form 4 on Codex DNA, Inc.|
Txns:
| Granted 74,611 shares
@ $0
Granted 111,917 options to buy
@ $1.93, valued at
$216k
|
|
| 07/22/2022 |
3
| TUMOLO ANNETTE (Director) has filed a Form 3 on Codex DNA, Inc. |
| 07/11/2022 |
4
| Hunter Brent M. (Vice President, Finance & PFO) has filed a Form 4 on Codex DNA, Inc.|
Txns:
| Granted 51,300 options to buy
@ $2.07, valued at
$106.2k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/15/2022 |
4/A
| Jackson Andrea Liapis (Director) has filed a Form 4 on Codex DNA, Inc. |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Jackson Andrea Liapis (Director) has filed a Form 4 on Codex DNA, Inc.|
Txns:
| Granted 20,630 shares
@ $0
Granted 30,945 options to buy
@ $3.49, valued at
$108k
|
|
| 03/01/2022 |
4
| Nelson Todd Robert (President & CEO) has filed a Form 4 on Codex DNA, Inc.|
Txns:
| Granted 183,500 options to buy
@ $0
Granted 47,900 restricted stock units
@ $0 |
|
| 03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2022 |
4
| Hunter Brent M. (Sr. Director Corp Controller) has filed a Form 4 on Codex DNA, Inc.|
Txns:
| Granted 13,500 options to buy
@ $0 |
|
| 03/01/2022 |
4
| Gibson Daniel Glenn (Chief Technology Officer) has filed a Form 4 on Codex DNA, Inc.|
Txns:
| Granted 84,700 options to buy
@ $0
Granted 22,100 restricted stock units
@ $0 |
|
| 09/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/07/2021 |
4
| Hunter Brent M. (Sr. Director Corp Controller) has filed a Form 4 on Codex DNA, Inc.|
Txns:
| Granted 5,500 options to buy
@ $11.75, valued at
$64.6k
|
|
| 06/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2021 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 06/24/2021 |
4
| Northpond Ventures GP, LLC (10% Owner) has filed a Form 4 on Codex DNA, Inc.|
Txns:
| Converted 9,375,380 shares
@ $0
Bought 468,750 shares
@ $16, valued at
$7.5M
Converted 5,214,851 preferred shares
@ $0
Converted 4,160,529 preferred shares
@ $0 |
|
|